<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01221064</url>
  </required_header>
  <id_info>
    <org_study_id>MUGSO-001</org_study_id>
    <nct_id>NCT01221064</nct_id>
  </id_info>
  <brief_title>Effect of Early vs Late Drainage Removal in Women After Radical Mastectomy With Axillary Clearance</brief_title>
  <acronym>CHLONKA</acronym>
  <official_title>Prospective Randomised Clinical Trial Comparing the Effect of Early and Late Drainage Removal in Female Patients After Radical Mastectomy With Axillary Clearance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess whether early drainage removal in patients with less than
      150ml of lymph in postoperative day 1 can reduce total lymphorrhoea
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with early drainage removal will be compared with patients in whom drainage will be
      kept until daily lymphorrhoea is 30ml
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total lymph volume and time</measure>
    <time_frame>3 months</time_frame>
    <description>Assessment of total lymph volume and lymphorrhoea time up to 3 months after the surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative pain assessment</measure>
    <time_frame>30 days</time_frame>
    <description>Post operative pain assessment using VAS (Visual Analogue Scale) scale until 30 days after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Early drainage removal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients randomised to early drainage removal arm will have the drain removed in postoperative day 1. Lymph will be punctured on a regular basis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late drainage removal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients randomised to late drainage removal arm will have the drains kept until total daily drainage is 30ml and then removed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Early drainage removal</intervention_name>
    <description>Drainage will be removed in postoperative day 1</description>
    <arm_group_label>Early drainage removal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Late drainage removal</intervention_name>
    <description>Drains will be kept until daily drainage is 30ml and then removed</description>
    <arm_group_label>Late drainage removal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage IIA and IIB breast cancer treated with radical mastectomy

          -  Obtaining informed consent

          -  Total amount of lymph in postoperative day 1 &lt;150ml

        Exclusion Criteria:

          -  Stage I, III-IV breast cancer

          -  History of benign breast neoplasm or malignant disease of any origin

          -  Any breast surgery in the past

          -  Weight &lt;50kg
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janusz Ja≈õkiewicz, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Gdansk</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacek Zielinski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Gdansk</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacek Zielinski, MD, PhD</last_name>
    <phone>660 123 402</phone>
    <phone_ext>+48</phone_ext>
    <email>jaziel@gumed.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pawel Kabata, MD</last_name>
    <phone>509 707 959</phone>
    <phone_ext>+48</phone_ext>
    <email>pakabata@uck.gda.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Gdansk, Department of Surgical Oncology</name>
      <address>
        <city>Gdansk</city>
        <state>Pomorskie</state>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Zielinsk, MD, PhD</last_name>
      <phone>660 123 402</phone>
      <phone_ext>+48</phone_ext>
      <email>jaziel@gumed.edu.pl</email>
    </contact>
    <contact_backup>
      <last_name>Pawel Kabata, MD</last_name>
      <phone>509 707 959</phone>
      <phone_ext>+48</phone_ext>
      <email>pakabata@uck.gda.pl</email>
    </contact_backup>
    <investigator>
      <last_name>Jacek Zielinski, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pawel Kabata, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maciej Bobowicz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Rak, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iwona Chruscicka, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Radoslaw Jaworski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2010</study_first_submitted>
  <study_first_submitted_qc>October 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2010</study_first_posted>
  <last_update_submitted>January 30, 2012</last_update_submitted>
  <last_update_submitted_qc>January 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Jacek Zielinski</investigator_full_name>
    <investigator_title>Assistant Profesor</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Axillary clearance</keyword>
  <keyword>lymphorrhoea</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

